Your privacy, your choice

We use essential cookies to make sure the site can function. We also use optional cookies for advertising, personalisation of content, usage analysis, and social media.

By accepting optional cookies, you consent to the processing of your personal data - including transfers to third parties. Some third parties are outside of the European Economic Area, with varying standards of data protection.

See our privacy policy for more information on the use of your personal data.

for further information and to change your choices.
Skip to main content

Table 12 (Abstract P092). Correlation between the percentage of ventilated patients developed VAP and use

From: 36th International Symposium on Intensive Care and Emergency Medicine

 

Slope

S. E.

r

r2

L. CI

U.CI

p value

Imipenem

-0.02

0.04

-0.32

0.10

-0.17

0.12

0.388

Meropenem

0.08

0.10

0.43

0.19

-0.24

0.42

0.460

Tigecyclin

0.10

0.06

0.66

0.43

-0.11

0.31

0.223

Linezoline

0.00

0.01

0.13

0.01

-0.03

0.04

0.834

Colistin

0.32

0.20

0.67

0.45

-0.32

0.96

0.210

Back to article page

Critical Care

ISSN: 1364-8535